Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Akebia Therapeutics, Inc. (AKBA)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 2.8 | 3.1 | 3.3 | 1.3 | 0.1 | | | |
| Asset turnover | 0.7 | 0.4 | 0.4 | 0.4 | 0.3 | 0.5 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -44.0% | -149.9% | -94.4% | -58.3% | -39.8% | -93.2% | -297.4% | -78.5% |
| ROIC (including intangibles) | -36.5% | -118.3% | -108.8% | -66.1% | -23.0% | -49.0% | -1710.1% | -73.4% |
| ROE | -676.3% | -347.0% | -105.4% | -70.8% | -23.4% | -62.6% | -200.3% | -47.0% |
| ROA | -18.0% | -50.5% | -40.5% | -36.3% | -14.9% | -21.1% | -45.5% | -43.0% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 48.9 | 86.9 | 33.2 | 42.3 | 29.3 | 68.9 | 8,042.6 | |
| Days payables outstanding | 77.6 | 79.9 | 51.0 | 98.5 | 2,010.9 | | | |
| Days inventory outstanding | 93.7 | 90.9 | 75.3 | 292.2 | 5,368.1 | | | |
| Cash conversion cycle | 65.0 | 97.9 | 57.5 | 236.1 | 3,386.5 | | | |
|